Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cost-effectiveness of ART in HIV Naive Patients
NCT02470650Phase 4Withdrawn
- Start
- Jun 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV). Planned start Jun 2015; status: withdrawn.
02
Drugs
elvitegravircobicistatemtricitabinetenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02470650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02470650.